318 related articles for article (PubMed ID: 25600367)
21. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug.
Sinkkonen ST; Mansikkamäki S; Möykkynen T; Lüddens H; Uusi-Oukari M; Korpi ER
Mol Pharmacol; 2003 Sep; 64(3):753-63. PubMed ID: 12920213
[TBL] [Abstract][Full Text] [Related]
22. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors.
Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM
Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950
[TBL] [Abstract][Full Text] [Related]
23. GABA
Chua HC; Chebib M
Adv Pharmacol; 2017; 79():1-34. PubMed ID: 28528665
[TBL] [Abstract][Full Text] [Related]
24. Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin.
Eghorn LF; Hoestgaard-Jensen K; Kongstad KT; Bay T; Higgins D; Frølund B; Wellendorph P
Eur J Pharmacol; 2014 Oct; 740():570-7. PubMed ID: 24973695
[TBL] [Abstract][Full Text] [Related]
25. GABA-induced uncoupling of GABA/benzodiazepine site interactions is mediated by increased GABAA receptor internalization and associated with a change in subunit composition.
Gutiérrez ML; Ferreri MC; Gravielle MC
Neuroscience; 2014 Jan; 257():119-29. PubMed ID: 24215979
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological subtypes of the gamma-aminobutyric acidA receptors defined by a gamma-aminobutyric acid analogue 4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol and allosteric coupling: characterization using subunit-specific antibodies.
Huh KH; Delorey TM; Endo S; Olsen RW
Mol Pharmacol; 1995 Oct; 48(4):666-75. PubMed ID: 7476892
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of benzodiazepine receptors: an update.
Sieghart W
J Psychiatry Neurosci; 1994 Jan; 19(1):24-9. PubMed ID: 8148363
[TBL] [Abstract][Full Text] [Related]
28. Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylation.
Macdonald RL; Twyman RE; Ryan-Jastrow T; Angelotti TP
Epilepsy Res Suppl; 1992; 9():265-77. PubMed ID: 1337441
[TBL] [Abstract][Full Text] [Related]
29. Protons inhibit Cl- conductance by direct or allosteric interaction with the GABA-binding site in the rat recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptor.
Wang MD; Rahman M; Zhu D
Eur J Pharmacol; 2005 Dec; 528(1-3):1-6. PubMed ID: 16325175
[TBL] [Abstract][Full Text] [Related]
30. Vasodilatory effects of a variety of positive allosteric modulators of GABA
Bojić MG; Todorović L; Santrač A; Mian MY; Sharmin D; Cook JM; Savić MM
Eur J Pharmacol; 2021 May; 899():174023. PubMed ID: 33722589
[TBL] [Abstract][Full Text] [Related]
31. Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes.
Ranna M; Sinkkonen ST; Möykkynen T; Uusi-Oukari M; Korpi ER
BMC Pharmacol; 2006 Jan; 6():1. PubMed ID: 16412217
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA
Nickolls SA; Gurrell R; van Amerongen G; Kammonen J; Cao L; Brown AR; Stead C; Mead A; Watson C; Hsu C; Owen RM; Pike A; Fish RL; Chen L; Qiu R; Morris ED; Feng G; Whitlock M; Gorman D; van Gerven J; Reynolds DS; Dua P; Butt RP
Br J Pharmacol; 2018 Feb; 175(4):708-725. PubMed ID: 29214652
[TBL] [Abstract][Full Text] [Related]
33. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
[TBL] [Abstract][Full Text] [Related]
34. Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABA(A) receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster.
Priestley CM; Williamson EM; Wafford KA; Sattelle DB
Br J Pharmacol; 2003 Dec; 140(8):1363-72. PubMed ID: 14623762
[TBL] [Abstract][Full Text] [Related]
35. A potent photoreactive general anesthetic with novel binding site selectivity for GABA
Shalabi AR; Yu Z; Zhou X; Jounaidi Y; Chen H; Dai J; Kent DE; Feng HJ; Forman SA; Cohen JB; Bruzik KS; Miller KW
Eur J Med Chem; 2020 May; 194():112261. PubMed ID: 32247113
[TBL] [Abstract][Full Text] [Related]
36. Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulator.
Yoshimura RF; Tran MB; Hogenkamp DJ; Johnstone TB; Xie JY; Porreca F; Gee KW
J Psychopharmacol; 2014 May; 28(5):472-8. PubMed ID: 24108410
[TBL] [Abstract][Full Text] [Related]
37. [GABA(A) benzodiazepine receptors and epilepsy].
Sieghart W
Wien Klin Wochenschr; 1990 Mar; 102(7):197-201. PubMed ID: 2160756
[TBL] [Abstract][Full Text] [Related]
38. Determining the relative efficacy of positive allosteric modulators of the GABAA receptor: design of a screening approach.
Ghisdal P; Noel N; Pacico N; Martini M; Foerch P; Hanon E; Wolff C
J Biomol Screen; 2014 Mar; 19(3):462-7. PubMed ID: 23989455
[TBL] [Abstract][Full Text] [Related]
39. Molecular Determinants Underlying Delta Selective Compound 2 Activity at
Falk-Petersen CB; Rostrup F; Löffler R; Buchleithner S; Harpsøe K; Gloriam DE; Frølund B; Wellendorph P
Mol Pharmacol; 2021 Jul; 100(1):46-56. PubMed ID: 33990405
[TBL] [Abstract][Full Text] [Related]
40. Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse.
Hondebrink L; Meulenbelt J; van Kleef RG; van den Berg M; Westerink RH
Neurotoxicology; 2011 Dec; 32(6):823-7. PubMed ID: 21729720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
